long-term effects of glp-1 receptor agonists GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment Peptide/GLP-1 Complications: 11 Hidden Risks
Description
The current research does not show that GLP-1 drugs directly target estrogen receptors, progesterone receptors, or HER2
New England Journal of Medicine, 388(3), 251263
Furthermore, a RCT (NCT03357380) is currently comparing the change in early stages of scar tissue as well as fat deposition in the liver, as detected by magnetic resonance imaging scans, in patients treated with semaglutide or placebo for 72 weeks
Signs that the starting dose is working Because the starting dose is intentionally low, the signs of it working are subtle
J Clin Endocrinol Metab (2020) 105:295063
